2017年版《美国成人高血压防治指南》解读

doi:10.12066/j.issn.1007-2861.2003

上海大学学报(自然科学版) ›› 2018, Vol. 24 ›› Issue (3): 331-335.doi: 10.12066/j.issn.1007-2861.2003

• 精准与转化医学 • 下一篇

2017年版《美国成人高血压防治指南》解读

潘新, 徐亚伟, 徐大春()

同济大学附属第十人民医院心内科, 上海 200072

收稿日期:2018-01-06 出版日期:2018-06-15 发布日期:2018-06-27
通讯作者: 徐大春 E-mail:xdc77@aliyun.com
基金资助:
国家自然科学基金资助项目(81270194);国家自然科学基金资助项目(81770391)

Interpretation of 2017 American Guideline for Hypertension in Adults

PAN Xin, XU Yawei, XU Dachun()

Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China

Received:2018-01-06 Online:2018-06-15 Published:2018-06-27
Contact: XU Dachun E-mail:xdc77@aliyun.com

摘要/Abstract

摘要：

2017年11月14日,美国心脏病学学会(American College of Cardiology, ACC)、美国心脏协会(American Heart Association, AHA)联合其他9大民间权威机构,发布了2017年版《美国成人高血压防治指南》(2017ACC/AHA).该版指南重新划分了高血压阈值, 设置了新的降压目标值,而不再延续执行先前已颁布10余年的高血压诊断标准. 该指南一经发布,就引起了全球范围的关注和争议, 后续所带来的冲击更是不容小觑.结合中国高血压现状对该指南进行初步解读.

关键词: 高血压, 指南, 解读

Abstract:

On November 14, 2017, American College of Cardiology (ACC) and American Heart Association (AHA), together with 9 other authorities, released 2017 American Guideline for Hypertension in Adults (2017ACC/AHA). The guideline no longer used the past diagnostic standard of hypertension, and it set up a new antihypertensive target. Ever since the issue of the guideline, experts and researchers around the world have been debating over the pros and cons of the new changes the guideline contains, and it can be expected that this guideline will continue to remain a controversial topic. This paper is an attempt to interpret the American guideline by taking into account the present situation in China.

Key words: hypertension, guideline, interpretation

中图分类号:

R544.1

潘新, 徐亚伟, 徐大春. 2017年版《美国成人高血压防治指南》解读[J]. 上海大学学报(自然科学版), 2018, 24(3): 331-335.

PAN Xin, XU Yawei, XU Dachun. Interpretation of 2017 American Guideline for Hypertension in Adults[J]. Journal of Shanghai University（Natural Science Edition）, 2018, 24(3): 331-335.

图/表 3

参考文献 12

[1]	W helton P K, C arey R M, A ronow W S, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines[J]. Hypertension, 2018,71(6):1269-1324. doi: 10.1161/HYP.0000000000000066 pmid: 29133354
[2]	L ewington S, C larke R, Q izilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies[J]. Lancet, 2002,361:1903-1913.
[3]	R apsomaniki E, T immis A, G eorge J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people[J]. Lancet, 2014,383:1899-1911. doi: 10.1016/S0140-6736(14)60685-1 pmid: 24881994
[4]	W illiamson J D, S upiano M A, A pplegate W B, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged $>$=75 years a randomized clinical trial[J]. Journal of the American Medical Association, 2016,315(24):2673-2682. doi: 10.1001/jama.2016.7050 pmid: 27195814
[5]	M untner P, C arey R M, G idding S, et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline[J]. Journal of the American College of Cardiology, 2018,71(2):109-118. doi: 10.1016/j.jacc.2017.10.073 pmid: 29146532
[6]	B angalore S, T oklu B, G ianos E, et al. Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials[J]. American Journal of Medicine, 2017,130(6):707-719. pmid: 28109971
[7]	D enardo S J, G ong Y, N ichols W W, et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy[J]. American Journal of Medicine, 2010,123(8):719-726. pmid: 20670726
[8]	C ushman W C, E vans G W, B yington R P, et al. Effects of intensive blood-pressure control in Type 2 diabetes mellitus[J]. New England Journal of Medicine, 2010,362(17):1575-1585. doi: 10.1056/NEJMoa1001286 pmid: 20228401
[9]	Z anchetti A, H ansson L, C lement D, et al. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?[J]. Journal of Hypertension, 2003,21(4):797-804. doi: 10.1097/00004872-200304000-00024 pmid: 12658027
[10]	L onn E M, B osch J, L opez-J aramillo P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease[J]. New England Journal of Medicine, 2016,374(21):2009-2020. doi: 10.1056/NEJMoa1600175 pmid: 27041480
[11]	L u J P, L u Y, W ang X C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE million persons project)[J]. Lancet, 2017,390:2549-2558. pmid: 29102084
[12]	W ang X B, Q in X H, D emirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis[J]. Lancet, 2007,369:1876-1882. doi: 10.1016/S0140-6736(07)60854-X pmid: 17544768

2017年版《美国成人高血压防治指南》解读

Interpretation of 2017 American Guideline for Hypertension in Adults

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

图/表 3

参考文献 12

相关文章 2

编辑推荐

Metrics

本文评价

[1]	邹玉宝, 惠汝太, 宋雷. 《中国成人肥厚型心肌病诊断与治疗指南》解读[J]. 上海大学学报(自然科学版), 2018, 24(1): 1-8.
[2]	邹长虹, 赵雪梅, 张宇辉. 《2014,年,ESC,肥厚型心肌病诊断和管理指南》解读[J]. 上海大学学报(自然科学版), 2018, 24(1): 16-20.